Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials

References

• FerrisFLPatzAMacular edema. A complication of diabetic retinopathySurv Ophthalmol198428Suppl4524616379946
   PubMed Web of Science ®Google Scholar
• PatzASchatzHBerkowJWGittelsohnAMTichoUMacular edema-an overlooked complication of diabetic retinopathyTrans Am Acad Ophthalmol Otolaryngol1973771OP34OP424738180
   PubMedGoogle Scholar
• KleinRKleinBEMossSECruickshanksKJThe Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edemaOphthalmology199510217167831044
   PubMed Web of Science ®Google Scholar
• AntonettiDABarberAJKhinSLiethETarbellJMGardnerTWVascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research GroupDiabetes19984712195319599836530
   PubMed Web of Science ®Google Scholar
• ChatziralliINicholsonLSivaprasadSHykinPIntravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trialsExpert Opin Biol Ther201515121685169726358547
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMAwhCCSustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III studyOphthalmology2011118102041204921715011
   PubMed Web of Science ®Google Scholar
• HeierJSCampochiaroPAYauLRanibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trialOphthalmology2012119480280922301066
   PubMed Web of Science ®Google Scholar
• CampochiaroPASophieRPearlmanJLong-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN studyOphthalmology2014121120921924112944
   PubMed Web of Science ®Google Scholar
• FarinhaCMarquesJPAlmeidaETreatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional OutcomeOphthalmic Res2015551101826540281
   PubMed Web of Science ®Google Scholar
• HallerJABandelloFBelfortRRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology201011761134114620417567
   PubMed Web of Science ®Google Scholar
• HallerJABandelloFBelfortRDexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study resultsOphthalmology2011118122453246021764136
   PubMed Web of Science ®Google Scholar
• MaggioEPolitoAGuerrieroMPertileGIntravitreal dexamethasone implant for macular edema secondary to retinal vein occlusion: 12-month follow-up and prognostic factorsOphthalmologica2014232420721525471901
   PubMed Web of Science ®Google Scholar
• FerriniWAmbresinAIntravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical settingKlin Monbl Augenheilkd2013230442342623629796
   PubMed Web of Science ®Google Scholar
• BezatisASpitalGHöhnFFunctional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up – the SOLO studyActa Ophthalmol2013915e340e34723638803
   PubMed Web of Science ®Google Scholar
• ChatziralliITheodossiadisGKabanarouSARanibizumab versus dexamethasone implant for central retinal vein occlusion: the RANIDEX studyGraefes Arch Clin Exp Ophthalmol2017255101899190528620704
   PubMed Web of Science ®Google Scholar
• CallananDGLoewensteinAPatelSSA multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edemaGraefes Arch Clin Exp Ophthalmol2017255346347327632215
   PubMed Web of Science ®Google Scholar
• HattenbachLOFeltgenNBertelmannTHead-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B)Acta Ophthalmol2018961e10e1828251811
   PubMed Web of Science ®Google Scholar
• HoeraufHFeltgenNWeissCClinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label StudyAm J Ophthalmol201616925826727163237
   PubMed Web of Science ®Google Scholar
• KarstSGLammerJMitschCDetailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatmentGraefes Arch Clin Exp Ophthalmol20182561495829080915
   PubMed Web of Science ®Google Scholar
• KissSLiuYBrownJClinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edemaClin Ophthalmol201481611162125210429
   PubMedGoogle Scholar
• NguyenQDBrownDMMarcusDMRanibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEOphthalmology2012119478980122330964
   PubMed Web of Science ®Google Scholar
• MitchellPBandelloFSchmidt-ErfurthUThe RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology2011118461562521459215
   PubMed Web of Science ®Google Scholar
• MassinPBandelloFGarwegJGSafety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes Care201033112399240520980427
   PubMed Web of Science ®Google Scholar
• CabreraMYehSAlbiniTASustained-Release Corticosteroid OptionsJ Ophthalmol20142014315
   Web of Science ®Google Scholar
• KuppermannBDBlumenkranzMSHallerJARandomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edemaArch Ophthalmol2007125330931717353400
   PubMed Web of Science ®Google Scholar
• BoyerDSYoonYHBelfortRThree-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edemaOphthalmology2014121101904191424907062
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMPearsonALong-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edemaOphthalmology2011118462663521459216
   PubMed Web of Science ®Google Scholar
• Chang-LinJEAttarMAcheampongAAPharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implantInvest Ophthalmol Vis Sci2011521808620702826
   PubMed Web of Science ®Google Scholar
• YumusakEBuyuktortopNOrnekKEarly results of dexamethasone implant, ranibizumab, and triamcinolone in macular edema due to branch retinal vein occlusionEur J Ophthalmol2016261545926109021
   PubMed Web of Science ®Google Scholar
• ComynOLightmanSLHykinPGCorticosteroid intravitreal implants vs. ranibizumab for the treatment of vitreoretinal diseaseCurr Opin Ophthalmol201324324825423518614
   PubMed Web of Science ®Google Scholar
• JadadARMooreRACarrollDAssessing the quality of reports of randomized clinical trials: is blinding necessary?Control Clin Trials19961711128721797
   PubMedGoogle Scholar
• ThomHHCapkunGNixonRMFerreiraAIndirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusionBMC Med Res Methodol20141414025533265
   PubMed Web of Science ®Google Scholar
• GuXYuXSongSDaiHIntravitreal dexamethasone implant versus intravitreal ranibizumab for the treatment of macular edema secondary to retinal vein occlusion in a Chinese populationOphthalmic Res201758181428334720
   PubMed Web of Science ®Google Scholar
• WellsJAGlassmanARAyalaARAflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trialOphthalmology201612361351135926935357
   PubMed Web of Science ®Google Scholar
• TamuraHMiyamotoKKiryuJIntravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retinaInvest Ophthalmol Vis Sci20054641440144415790913
   PubMed Web of Science ®Google Scholar
• TangJKernTSInflammation in diabetic retinopathyProg Retin Eye Res201130534335821635964
   PubMed Web of Science ®Google Scholar
• AdamisAPBermanAJImmunological mechanisms in the pathogenesis of diabetic retinopathySemin Immunopathol2008302658418340447
   PubMed Web of Science ®Google Scholar
• JonasJBJonasRANeumaierMFindeisenPCytokine concentration in aqueous humor of eyes with diabetic macular edemaRetina201232102150215722617833
   PubMed Web of Science ®Google Scholar
• LazicRLukicMBorasITreatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implantRetina201434471972423975006
   PubMed Web of Science ®Google Scholar
• ThomasBJYonekawaYWolfeJDHassanTSContralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edemaClin Ophthalmol2016101679168427621587
   PubMedGoogle Scholar
• Schmidt-ErfurthUGarcia-ArumiJBandelloFGuidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA)Ophthalmologica2017237418522228423385
   PubMed Web of Science ®Google Scholar
• BoyerDSFaberDGuptaSDexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patientsRetina201131591592321487341
   PubMed Web of Science ®Google Scholar